53BP1 Contributes to Igh Locus Chromatin Topology during Class Switch Recombination
In B lymphocytes, Ig class switch recombination (CSR) is induced by activation-induced cytidine deaminase, which initiates a cascade of events leading to DNA double-strand break formation in switch (S) regions. Resolution of DNA double-strand breaks proceeds through formation of S–S synaptic complex...
Saved in:
Published in | The Journal of immunology (1950) Vol. 198; no. 6; pp. 2434 - 2444 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association of Immunologists
15.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In B lymphocytes, Ig class switch recombination (CSR) is induced by activation-induced cytidine deaminase, which initiates a cascade of events leading to DNA double-strand break formation in switch (S) regions. Resolution of DNA double-strand breaks proceeds through formation of S–S synaptic complexes. S–S synapsis is mediated by a chromatin loop that spans the C region domain of the Igh locus. S–S junctions are joined via a nonhomologous end joining DNA repair process. CSR occurs via an intrachromosomal looping out and deletion mechanism that is 53BP1 dependent. However, the mechanism by which 53BP1 facilitates deletional CSR and inhibits inversional switching events remains unknown. We report a novel architectural role for 53BP1 in Igh chromatin looping in mouse B cells. Long-range interactions between the Eμ and 3′Eα enhancers are significantly diminished in the absence of 53BP1. In contrast, germline transcript promoter:3′Eα looping interactions are unaffected by 53BP1 deficiency. Furthermore, 53BP1 chromatin occupancy at sites in the Igh locus is B cell specific, is correlated with histone H4 lysine 20 marks, and is subject to chromatin spreading. Thus, 53BP1 is required for three-dimensional organization of the Igh locus and provides a plausible explanation for the link with 53BP1 enforcement of deletional CSR. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Current address: Cancer Vaccine Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115 Current address: Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 Current address: Department of Medicine, University of Arizona College of Medicine – Tucson, Tucson, AZ 85724 |
ISSN: | 0022-1767 1550-6606 1550-6606 |
DOI: | 10.4049/jimmunol.1601947 |